CMS Cites OM1 Led Outcomes Standardization Effort In Treatment Resistant Depression Memo
Read the decision memo: https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=292
Showing 151-155 of 172 news & articles:
OM1 Rheumatoid Arthritis Registry Reaches More Than 100,000 Patients Prospectively Followed With Deep Clinical Data
BOSTON, January 16, 2019 — OM1, a leading health outcomes, registries and technology company creating solutions to better understand, compare, and predict patient outcomes, today announced that its Rheumatoid Arthritis (RA) registry has reached more than 100,000 patients with deep clinical data and is available for licensing, studies and advanced analytics. RA is a chronic autoimmune[…]
OM1 Named One Of The Most Innovative Startups Of 2018 By PM360
December 18, 2018 – PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named OM1 as one of the most innovative Services of 2018. Founded in 2015, OM1 is a health outcomes and technology company leveraging big clinical data, standardized outcome measurement, and artificial intelligence[…]
Applying AI for personalized treatment decisions and lowering costs in orthopedics
Becker’s Spine Review | Written by Richard Gliklich, MD, CEO, OM1 | November 26, 2018 In healthcare, results really matter Understanding why certain treatments and procedures work better on some patients and not so well on others is the key to delivering more personalized care and ultimately achieving better results for all stakeholders in the care process.[…]
New Harmonized Outcome Measures for Atrial Fibrillation Published in HeartRhythm
November 15, 2018 —OM1, a leading health outcomes and technology company, today announced the publication of new harmonized outcome measures for atrial fibrillation (AF) in HeartRhythm. OM1’s Richard Gliklich and Michelle Leavy collaborated on the development of the measures and co-authored the publication. The work was funded by the Agency for Healthcare Research and Quality (AHRQ) through[…]